Introduction
In patients with rheumatoid arthritis (RA) there is a high incidence of impaired renal function, with evidence of reduced glomerular filtration' -4 and tubular function.5 Structural changes have also been found at necropsy in the kidneys of 72% of sufferers from RA compared with 25% of a control group. 6 Nevertheless, it is difficult to differentiate between the disease itself and drug treatment as the cause of the renal damage.
Excretion of f-glycosidase enzymes is increased in several renal diseases,7 and measurement of N-acetyl-3-D-glucosamini- serum, and synovial fluid samples that had been collected on the same day. These samples were also used for estimating the isoenzyme patterns in the three fluids. The NAG isoenzyme pattern in the urine was similar to that in renal tissue-namely, As+ B (using the notation of Ellis et all8)-and the isoenzyme patterns in serum and synovial fluid were similar-A+B. The NAG activity in synovial fluid and urine was higher than that in the serum. There was no correlation between serum, urine, and synovial fluid NAG levels in the different samples: synovial fluid (509-6±288-6 nmol/l) v serum (288-0 ±46-6 nmol/l) r = 0-28; synovial fluid v urine (669-9 ±393-9 nmol h-' mg creatinine-') r = 0-3; serum v urine r = 0-43.
Correlation of urinary NAG levels with disease activity-In 60 patients with RA the urinary activity of NAG was correlated with various indices of disease activity and with the duration of the disease. There was no correlation with the duration of the disease, but there was a significant correlation with several of the measurements used to assess the activity of the disease (table II) 
Discussion
The urinary activity of the enzyme NAG is a sensitive index of renal disease in man7 and is currently used as an early warning of renal graft rejection. 8 A simple automated technique of estimation has been developed'6 and by expressing the results in relation to creatinine excretion errors due to estimating random samples from people with different glomerular function can be overcome.' 7 In addition, none of our patients had severely impaired renal function, as measured by 24-hour creatinine clearance. A preliminary study showed that the excretion of NAG was higher in patients with RA than in those with other rheumatological diseases,9 and the present study showed that the urinary enzyme activity is much higher in rheumatoid patients than in normal controls. We also found, like others,' 9 2 0 that lysosomal enzyme activity is high in rheumatoid synovial fluid. Other workers have also reported an increase in serum NAG activity in RA," 22 and our results agree with theirs, though the difference from the control group was small and the groups were not perfectly matched for age and sex.
The increase in NAG levels in synovial fluid and serum raised the possibility that the urinary increase was due to filtration of the enzyme. But there are several points against this. Firstly, the enzyme has a molecular weight of 160 000 and should not leak into the urine in the absence of appreciable proteinuria, and all patients with proteinuria were excluded. Secondly, we could not show any correlation between levels of the enzyme in synovial fluid, serum, and urine. Thirdly, the isoenzyme pattern of NAG in urine differs from that in serum and synovial fluid, but it is identical with that found in extracts of renal tissue.18 This is strong evidence that the urinary enzyme is derived from the kidney.
The positive correlation between urinary NAG activity and indices of disease activity could have two explanations. Either more severe RA tended to affect the kidneys more or patients with more severe disease received more nephrotoxic treatment. Unfortunately, because of the complexity of rheumatoid drug histories, we could not correlate NAG excretion with individual drug treatment, although it was apparent that many patients with the highest levels had had the disease for only a short time and had received little treatment. Other work suggests, however, that salicylates can increase NAG excretion, and that other drugs may have a similar effect, so drugs might have contributed an important part of the overall increase in urinary NAG. 9 23 24 To try to find out whether rheumatoid disease alone could increase NAG excretion urinary activity was measured in 20 patients who had received no drug treatment for their disease. In eight of these 20 patients levels were abnormally high, which strongly suggested the presence of a renal lesion. Although renal abnormalities are common in RA5 6 characteristic changes are recognised only with amyloidosis, Sjogren's syndrome, and analgesic nephropathy; no patients with these disorders were included in this study. The evidence therefore favours a renal lesion specific to rheumatoid disease itself. 
